用户对药品标签上传递说明和警告的图形和图片的解释
Destyn Jones1, Sabrina Moran2, Jaime Sanchez2
1Building Infrastructure Leading to Diversity (BUILD) Program, California State University, Long Beach, Long Beach, CA 90815, USA.
Human interface and the management of information. Visual information and knowledge management : thematic area, HIMI 2019, held as part of the 21st HCI Interrnational Conference, HCII 2019, Orlando, FL, USA, July 26-31, 2019, Proceeding...
|September 5, 2024
概括
与药品图形相比,药品标签上的真实图像并没有改善患者的理解. 目前的图形图表理解仍然适度准确,但需要进一步改进,以更好地遵守药物治疗.
科学领域:
- 卫生沟通健康沟通
- 人与计算机的交互
- 患者安全 患者安全
背景情况:
- 药物不良服药是严重的公共卫生问题,往往源于患者对药物标签的误解.
- 制药图标是为了在视觉上传达药物说明和警告而开发的,旨在提高理解力.
- 现有研究表明,虽然图标可以帮助理解,但目前的理解率仍然不够理想.
研究的目的:
- 调查真实图像 (图片) 与传统图标相比,是否能更好地理解药物说明和警告.
- 测试假设具体,简单,有意义和熟悉的真实图像可以提高用户对药物标签信息的理解.
主要方法:
- 参与者进行了一项在线调查,以评估他们对药物标签信息的理解,这些信息以图形图表或真实图像的形式呈现.
- 收集了定量和定性数据,包括自由反应答案和用户对刺激有效性的评分.
- 评估了参与者解释图形图和真实图像的准确性.
主要成果:
- 参与者在解释药品图标的含义时表现出中等准确度 (74%).
- 与图形图表相比,使用真实图像并没有显著改善患者对药物说明或警告的理解.
- 定性和定量分析不支持假设真实图像增强理解.
结论:
- 现实图像本身并不能比现有的图形图表更好地提高患者对药物说明的理解.
- 需要进一步的研究来开发更有效的视觉辅助工具,满足具体,简单,有意义和熟悉的标准.
- 改进图形图形设计对于改善药物服药和患者安全至关重要.
更多相关视频
10:16Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
Published on: March 12, 2019
44.2K
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
8.4K
相关概念视频
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:26Drug Administration and Therapy Phases: Overview
418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
01:19Pharmacovigilance
789
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
789
01:17Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
01:30Guidelines for Nursing Documentation I
1.0K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
1.0K